Lilly’s New Weight-Loss Pill Foundayo Gets Off to a Slow Start
Lilly’s new weight-loss pill started slow, far behind Novo’s, but it’s too early to tell which drug will win.
Already have an account? Sign in.
Lilly’s new weight-loss pill started slow, far behind Novo’s, but it’s too early to tell which drug will win.
LITE reports robust Q4, lifts guidance, and reaches long-term model early.
Quantinuum tops estimates in first public earnings, raises 2026 outlook, and partners with Oracle to deploy Helios quantum computer in the cloud.
Singapore’s Temasek is considering increasing its stakes in Samsung Electronics and SK Hynix through its internal investment team.